Ledger.Open graph →
SEC Form D · Amendment · filed December 12, 2024

Resilient Biotics, Inc

Offering
$4.6M
Sold
$3.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RESEARCH TRIANGLE PARK, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Daniel R. Bhattachar · Durham, NCExec · DirectorEric Eason · Durham, NCDirectorJohn Peryam · Durham, NCDirectorRachelle Galvin · Durham, NCExec · DirectorDrew Lanza · Durham, NCDirectorChristopher Belnap · Durham, NCExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗